Jobs / United States / Glaxosmithkline LLC
Associate Director, Associate Clinical Operations Asset Lead (aCOAL)
Glaxosmithkline LLC · 🇺🇸 6 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles4 certified filings for “Associate Director – Genomic Technologies” (Molecular and Cellular Biologists) in PA: $134k–$138k, median $136k. Most were filed at wage level IV (50%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success. We’re uniting science, technology, and talent to get ahead of disease together. Find out more: Our approach to R&D For candidates seeking to be located at our Stevenage site, this role will temporarily be based at Stevenage. However, the Company plans to relocate its offices to Cambridge, UK. The location of this role will therefore subsequently change to Cambridge, UK in accordance with timelines to be set by the Company. The relocation is currently proposed to take effect by early 2029. Position Summary You will support and lead operational delivery for complex oncology late clinical assets. You will work closely with EDT/MDT, Study Team and COAL to keep studies inspection ready and deliver high-quality, regulatory-grade data. We value clear decision making, collaborative leadership, and practical problem solving. This role offers strong growth, the chance to influence program strategy, and the opportunity to help GSK unite science, technology and talent to get ahead of disease together. Key Responsibilities This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following: • Lead and support the operational strategy and delivery for assigned late phase development streams, ensuring alignment with the clinical development plan. • Coordinate cross-functional inputs from clinical, biostatistics, safety, clinical supplies and vendors to meet timelines and quality expectations. • Represent DevOps at EDT/MDT. • Contribute to protocol development, operational feasibility assessments and resourcing decisions, including insourcing versus outsourcing recommendations. • Maintain inspection readiness and quality oversight, supporting risk management, mitigation plans and serious breach escalation when needed. • Provide operational input for regulatory deliverables and governance forums, including scenario modelling and budget forecasting for clinical activities. • Act as a point of contact for stakeholders and vendors to ensure consistent execution across studies and sub-projects. Why You ? Basic Qualification We are seeking professionals with the following required skills and qualifications to help us achieve our goals • Bachelor’s degree in life sciences, health sciences or equivalent qualification. • Experience in oncology clinical development. • Experience in vendor management and oversight of Contract Research Organization (CRO) relationships. • Experience working in roles requiring application of Good Clinical Practice (GCP) and clinical development processes • Experience delivering global study oversight across multiple regions. Preferred Qualification If you have the following characteristics, it would be a plus • Experience managing multiple stakeholders and communicating in written and verbal English in a professional setting. • Experience in Phase II-III programs. • Working on complex, multi-indication programs. • Experience in clinical operations, clinical project or program management. • Experience contributing to regulatory submission content or supporting regulatory interactions. • Experience with budgeting and forecasting for clinical studies. • Fam